Over-the-counter hearing aids expected this fall in US




  • In World
  • 2022-08-16 14:16:03Z
  • By Associated Press
 

WASHINGTON (AP) - Millions of Americans will be able to buy hearing aids without a prescription later this fall, under a long-awaited rule finalized Tuesday.

The Food and Drug Administration said the new regulation cuts red tape by creating a new class of hearing aids that don't require a medical exam, a prescription and other specialty evaluations. Instead the devices will be sold online or over-the-counter at pharmacies and other retail stores.

The devices are intended for adults with mild to moderate hearing problems. The FDA estimates that nearly 30 million adults could potentially benefit from hearing aid use, but only about one-fifth of people with hearing problems use the devices currently. The FDA first proposed the rule last October. The new rule will take effect in mid-October.

Biden administration officials highlighted the potential cost savings.

"Today's action by the FDA represents a significant milestone in making hearing aids more cost-effective and accessible," Health and Human Services Secretary Xavier Becerra, said in a statement.

The move follows years of pressure from medical experts and consumer advocates to make the devices cheaper and easier to get.

Cost is a big obstacle now. Between the device itself and fitting services, Americans can pay more than $5,000 to get a hearing aid. Insurance coverage is very limited, and Medicare doesn't pay for hearing aids, only diagnostic tests.

The new over-the-counter status won't apply to devices for more severe hearing loss, which will remain prescription only.

Consumer electronic companies for years have produced lower-cost "personal sound amplification" devices, but U.S. regulations bar them from being marketed as hearing aids and they do not undergo FDA review. The new rule makes explicit that those devices are not alternatives to FDA-vetted hearing aids. Companies that market them inappropriately could face penalties, such as fines or product seizures.

The FDA said it changed several parts of its initial proposal in response to public comments, including clarifying how the federal rule will impact state regulations on hearing aids.

Once the federal rule takes effect, traditional manufacturers are expected to begin selling cheaper, direct-to-consumer models. Eventually, advocates predict the hearing aid market will resemble eye care, where consumers can choose between drugstore reading glasses or prescription bifocals.

Tuesday's announcement follows prodding from medical committees and Congress, which in 2017 instructed the agency to lay out a plan for over-the-counter hearing devices.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

COMMENTS

More Related News

U.S. FDA clears additional lots of Moderna
U.S. FDA clears additional lots of Moderna's Covid booster amid shortage

Last week, the health regulator had allowed use of ten batches of Moderna's updated booster shots made at the Bloomington, Indiana facility, owned by a unit of Catalent Inc, which is currently not a part of the company's emergency use authorization. The FDA had earlier said Moderna had requested authorization for additional batches in light of the current supply issues.

Insider Q&A: FDA official on vaping
Insider Q&A: FDA official on vaping's "promise or peril"

There's been no honeymoon period for the Food and Drug Administration's new tobacco chief, Brian King, the public health scientist now responsible for regulating the nation's multibillion-dollar cigarette and vaping industry. The problems facing FDA's Center for Tobacco Products have only multiplied since King's arrival in July from the Centers for Disease Control and Prevention. The FDA missed a summer deadline to review nearly a million applications for e-cigarettes and other new products that use laboratory-made nicotine, some of which have become popular teenagers.

Pfizer-BioNTech asks FDA to authorize new omicron-targeting COVID booster for children 5 to 11
Pfizer-BioNTech asks FDA to authorize new omicron-targeting COVID booster for children 5 to 11

Pfizer-BioNTech submitted an application for the FDA to authorize its BA.4/BA.5 bivalent COVID-19 vaccine for kids 5 to 11 at a 10-microgram dose.

Pfizer seeks to expand omicron booster to 5- to 11-year-olds
Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11. If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster. FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: World